Bloomage Biotechnology Corp Ltd
SSE:688363

Watchlist Manager
Bloomage Biotechnology Corp Ltd Logo
Bloomage Biotechnology Corp Ltd
SSE:688363
Watchlist
Price: 57.5 CNY -5.46% Market Closed
Market Cap: 27.7B CNY
Have any thoughts about
Bloomage Biotechnology Corp Ltd?
Write Note

Relative Value

The Relative Value of one Bloomage Biotechnology Corp Ltd stock under the Base Case scenario is 96.44 CNY. Compared to the current market price of 57.5 CNY, Bloomage Biotechnology Corp Ltd is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
96.44 CNY
Undervaluation 40%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
83
vs Industry
64
Median 3Y
7.5
Median 5Y
11.5
Industry
7.7
Forward
4.4
vs History
67
vs Industry
4
Median 3Y
58
Median 5Y
69.3
Industry
22.7
Forward
39
vs History
85
vs Industry
6
Median 3Y
59.3
Median 5Y
75.3
Industry
21.6
vs History
vs Industry
0
Median 3Y
-69.8
Median 5Y
-97.7
Industry
25.2
vs History
87
vs Industry
21
Median 3Y
7
Median 5Y
9.6
Industry
2.5
vs History
83
vs Industry
55
Median 3Y
7.3
Median 5Y
11.1
Industry
7.7
Forward
4.3
vs History
83
vs Industry
48
Median 3Y
9.7
Median 5Y
14.3
Industry
9
vs History
69
vs Industry
3
Median 3Y
49.5
Median 5Y
57.9
Industry
4.2
Forward
24.7
vs History
69
vs Industry
3
Median 3Y
49.5
Median 5Y
57.9
Industry
4.1
Forward
34.1
vs History
83
vs Industry
5
Median 3Y
57.6
Median 5Y
73.6
Industry
5.7
vs History
vs Industry
0
Median 3Y
-168.9
Median 5Y
-221.1
Industry
3.6
vs History
88
vs Industry
33
Median 3Y
7.4
Median 5Y
13.1
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Bloomage Biotechnology Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
27.7B CNY 4.8 54.3 45.9 45.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average P/E: 182.6
54.3
85%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average EV/EBITDA: 21.3
45.9
123%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average EV/EBIT: 25.9
45.9
73%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top